“Efficacy of Bevacizumab to Reduce Lid Margin Vascularity and Alteration in Tear Film Status” (2021) Annals of King Edward Medical University, 27(Special Issue (Jul-Sep), pp. 368–371. doi: 10.21649/akemu.v27iSpecial Issue (Jul-Sep).4656.